Raymond James Financial’s Calumet Specialty Products CLMT Stock Holding History

Raymond James Financial’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.75M	Sell	187,905 -308,056	-62%	-$7.98M	﹤0.01%	2351
2025 Q4	$9.85M	Sell	495,961 -22,095	-4%	-$425K	﹤0.01%	1982
2025 Q3	$9.45M	Sell	518,056 -15,965	-3%	-$263K	﹤0.01%	1964
2025 Q2	$8.41M	Sell	534,021 -8,332	-2%	-$106K	﹤0.01%	2002
2025 Q1	$6.88M	Buy	542,353 +21,704	+4%	+$341K	﹤0.01%	2094
2024 Q4	$11.5M	Buy	+520,649	New	+$10.9M	﹤0.01%	1737

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Raymond James Financial's CLMT Position: Q1 2026 in Review

Raymond James Financial reduced its Calumet Specialty Products (CLMT) stake by 62% in Q1 2026, selling an estimated $7.98M and leaving 187,905 shares worth $6.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Raymond James Financial first reported a position in CLMT in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.5M in Q4 2024. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

Raymond James Financial held 187,905 shares of Calumet Specialty Products worth $6.75M as of Q1 2026.
Raymond James Financial sold 308,056 Calumet Specialty Products shares in Q1 2026, an estimated $7.98M.
Calumet Specialty Products made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2351 holding.
Raymond James Financial first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Calumet Specialty Products position peaked at $11.5M in Q4 2024.
180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.